Emergent BioSolutions Inc. (EBS)
NYSE·Healthcare·Biotechnology
$7.41
+1.30%
Mkt Cap $374.59M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+62.1%
Consensus $12.00 vs current $7.41
NYSE·Healthcare·Biotechnology
$7.41
+1.30%
Mkt Cap $374.59M
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$12.00
Range $12.00 – $12.00
+62.1%
Consensus $12.00 vs current $7.41